https://www.selleckchem.com/pr....oducts/Puromycin-2HC
y assessed by dGEMRIC 20 years after injury. Chitosan supplementation has been shown to modulate glycemic levels; however, studies have reported conflicting results. The present meta-analysis with trial sequential analysis was conducted to verify the overall influence of chitosan on glycemic levels in patients with metabolic syndrome. The PubMed, Cochrane library, and EMBASE databases were systematically searched for randomized controlled studies of chitosan intake and glycemic levels. A total of ten clinical trials including 147
Like
Comment
Share
